Yin-yang genetics, or the HSD deCODE controversy

Area of Science:

• Bioethics
• Genomics
• Public Health Law

Background:

• The Icelandic Health Sector Database Act of 1998 and deCODE Genetics generated significant international controversy.
• Key issues include the balance of state power, ethical considerations in genetic research, and the protection of civil liberties.
• The dual nature of deCODE Genetics, being both international and Icelandic, complicates the regulatory landscape.

Purpose of the Study:

• To analyze the controversy surrounding the Icelandic Health Sector Database Act and deCODE Genetics.
• To explore the ethical, legal, and civil liberty implications of large-scale genetic databases.
• To understand the complex relationship between the Health Sector Database and deCODE Genetics.

Main Methods:

• Review of the Icelandic Health Sector Database Act of 1998.
• Analysis of deCODE Genetics' operations and its relationship with the Icelandic government.
• Examination of ethical and legal debates concerning genetic data and privacy.

Main Results:

• The controversy highlights tensions between public health initiatives, commercial genetic research, and individual rights.
• Concerns exist regarding the potential for the Health Sector Database to encompass the entire Icelandic population.
• The international and Icelandic affiliations of deCODE Genetics present unique regulatory challenges.

Conclusions:

• The Icelandic case serves as a critical study on the governance of genetic information.
• Balancing scientific advancement with bioethical principles and civil liberties is paramount.
• Clearer regulations are needed to address the complexities of national genetic databases and private genomics companies.